Your browser doesn't support javascript.
loading
FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.
Stintzing, Sebastian; Heinrich, Kathrin; Tougeron, David; Modest, Dominik Paul; Schwaner, Ingo; Eucker, Jan; Pihusch, Rudolf; Stauch, Martina; Kaiser, Florian; Kahl, Christoph; Karthaus, Meinolf; Müller, Christian; Burkart, Christof; Reinacher-Schick, Anke; Kasper-Virchow, Stefan; Fischer von Weikersthal, Ludwig; Krammer-Steiner, Beate; Prager, Gerald Wolfgang; Taieb, Julien; Heinemann, Volker.
Affiliation
  • Stintzing S; Department of Hematology, Oncology, and Cancer Immunology (CCM), Charité-Universitaetsmedizin Berlin, Germany.
  • Heinrich K; German Cancer Consortium (DKTK), partner site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tougeron D; Department of Oncology, LMU University Hospital, Munich, Germany.
  • Modest DP; Department of Hepato-Gastroenterology, Poitiers University Hospital and University of Poitiers, Poitiers, France.
  • Schwaner I; Department of Hematology, Oncology, and Cancer Immunology (CCM), Charité-Universitaetsmedizin Berlin, Germany.
  • Eucker J; Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin, Germany.
  • Pihusch R; Department of Hematology, Oncology, and Cancer Immunology (CBF), Charité-Universitaetsmedizin Berlin, Germany.
  • Stauch M; MVZ Praxis Pihusch, Rosenheim, Germany.
  • Kaiser F; Hematology, Oncology/Hemostaseology Kronach, Kronach, Germany.
  • Kahl C; VK&K Oncology GmbH, Landshut, Germany.
  • Karthaus M; Klinikum Magdeburg gGmbH, Department of Hematology, Oncology and Palliative Care Magdeburg, Germany.
  • Müller C; Department of Internal Medicine, Clinic III-Hematology, Oncology and Palliative Care, Rostock University Medical Center, Rostock, Germany.
  • Burkart C; Department of Hematology, Oncology and Palliative Care, München Klinik Harlaching and Neuperlach, Munich, Germany.
  • Reinacher-Schick A; Evang. Kliniken Essen-Mitte, Essen, Germany.
  • Kasper-Virchow S; Schwarzwald-Baar Klinikum Villingen-Schwenningen, Germany.
  • Fischer von Weikersthal L; Department of Hematology, Oncology and Palliative Care, St Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Krammer-Steiner B; West German Cancer Center, Department of Medical Oncology, University Hospital Essen, Essen, Germany.
  • Prager GW; Gesundheitszentrum St Marien, Amberg, Germany.
  • Taieb J; Department of Hematology and Oncology; Klinikum Rostock Südstadt, Rostock, Germany.
  • Heinemann V; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.
J Clin Oncol ; 41(25): 4143-4153, 2023 09 01.
Article de En | MEDLINE | ID: mdl-37352476
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du rectum / Tumeurs colorectales / Tumeurs du côlon Type d'étude: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: J Clin Oncol Année: 2023 Type de document: Article Pays d'affiliation: Allemagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du rectum / Tumeurs colorectales / Tumeurs du côlon Type d'étude: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limites: Humans Langue: En Journal: J Clin Oncol Année: 2023 Type de document: Article Pays d'affiliation: Allemagne